WAKEFIELD, MA, Feb. 13 /PRNewswire-FirstCall/ - NUCRYST PharmaceuticalsCorp. will hold a webcast at 5:00 p.m. EST on Thursday, February 14, 2008regarding the company's 2007 fourth quarter results.
In addition to standard disclosure over wire services, a news release andfinancial statements will be posted on the NUCRYST web site. To listen to thecall live on the Internet, please go to www.nucryst.com.
Thomas E. Gardner, Chairman, President, & CEO and Eliot M. Lurier, VicePresident, Finance & Administration, and CFO will participate on the call.
An audio file of the call will be archived and posted on the NUCRYST website.
NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufacturesand commercializes medical products that fight infection and inflammationusing its patented atomically disordered nanocrystalline silver technology.Smith & Nephew plc sell a range of advanced wound care products under theirActicoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST'sSILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is alsodeveloping pharmaceutical products to address medical conditions that arecharacterized by both infection and inflammation. The company has developedits proprietary nanocrystalline silver in a powder form, referred to as NPI32101 for use in medical devices and as an active pharmaceutical ingredient.
SOURCE NUCRYST Pharmaceuticals Corp.